The in vivo experiments were performed over a loner time-period, indicating that the inhibitory effects of CDX2 on colorectal cancer were time-dependent and the short-term effects were not significant, but CDX2 may inhibit tumor growth over a longer duration. Here, CDX2 is linked to neoplasm.